Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-05-30
1979-10-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260455A, 260562A, 260562R, 260557R, 424311, 560 27, 2603264, 2603265S, 26032681, 546234, A61K 3122, A61K 31165, C07C15503, C07C15707
Patent
active
041728980
ABSTRACT:
N-(2-aminocycloheptyl)-N-alkanoylanilides and their 2-N-oxides of the formula ##STR1## e.g., trans-3,4-dichloro-N-[2-(dimethylamino)cycloheptyl]acrylanilide, and their pharmacologically acceptable salts, have been found to possess potent Central Nervous System anti-depressant properties. Many of them are new.
These compounds are promising anti-depressant drugs which are characterized by lower toxicity than imipramine, and long acting activity which may allow longer durations between administrations, e.g., once a day. Pharmaceutical compositions containing these compounds and a process for treating conditions of depression with these compositions are disclosed.
REFERENCES:
patent: 3510492 (1970-05-01), Szmuszkovicz
Friedman Stanley J.
Reynolds John T.
The Upjohn Company
LandOfFree
N-(2-aminocycloheptyl)acylanilides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(2-aminocycloheptyl)acylanilides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-aminocycloheptyl)acylanilides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-20321